| KRAS Mutation Status Is Predictive of Response to Cetuximab Therapy in Colorectal Cancer A Lievre, JB Bachet, D Le Corre, V Boige, B Landi, JF Emile, JF Côté, ... Cancer research 66 (8), 3992-3995, 2006 | 2821 | 2006 |
| The 5th edition of the World Health Organization classification of haematolymphoid tumours: myeloid and histiocytic/dendritic neoplasms JD Khoury, E Solary, O Abla, Y Akkari, R Alaggio, JF Apperley, R Bejar, ... leukemia 36 (7), 1703-1719, 2022 | 2019 | 2022 |
| KRAS Mutations As an Independent Prognostic Factor in Patients With Advanced Colorectal Cancer Treated With Cetuximab A Lievre, JB Bachet, V Boige, A Cayre, D Le Corre, E Buc, M Ychou, ... Journal of clinical oncology 26 (3), 374-379, 2008 | 1960 | 2008 |
| Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages JF Emile, O Abla, S Fraitag, A Horne, J Haroche, J Donadieu, ... Blood, The Journal of the American Society of Hematology 127 (22), 2672-2681, 2016 | 1390 | 2016 |
| Interferon-γ–receptor deficiency in an infant with fatal bacille Calmette–Guérin infection E Jouanguy, F Altare, S Lamhamedi, P Revy, JF Emile, M Newport, ... New England Journal of Medicine 335 (26), 1956-1962, 1996 | 1123 | 1996 |
| Impairment of mycobacterial immunity in human interleukin-12 receptor deficiency F Altare, A Durandy, D Lammas, JF Emile, S Lamhamedi, F Le Deist, ... Science 280 (5368), 1432-1435, 1998 | 1066 | 1998 |
| Foamy Macrophages from Tuberculous Patients' Granulomas Constitute a Nutrient-Rich Reservoir for M. tuberculosis Persistence P Peyron, J Vaubourgeix, Y Poquet, F Levillain, C Botanch, F Bardou, ... PLoS pathogens 4 (11), e1000204, 2008 | 860 | 2008 |
| Rituximab plus CHOP (R-CHOP) overcomes bcl-2—associated resistance to chemotherapy in elderly patients with diffuse large B-cell lymphoma (DLBCL) N Mounier, J Briere, C Gisselbrecht, JF Emile, P Lederlin, C Sebban, ... Blood 101 (11), 4279-4284, 2003 | 718 | 2003 |
| High prevalence of BRAF V600E mutations in Erdheim-Chester disease but not in other non-Langerhans cell histiocytoses J Haroche, F Charlotte, L Arnaud, A Von Deimling, Z Hélias-Rodzewicz, ... Blood, The Journal of the American Society of Hematology 120 (13), 2700-2703, 2012 | 699 | 2012 |
| Dramatic efficacy of vemurafenib in both multisystemic and refractory Erdheim-Chester disease and Langerhans cell histiocytosis harboring the BRAF V600E … J Haroche, F Cohen-Aubart, JF Emile, L Arnaud, P Maksud, F Charlotte, ... Blood, The Journal of the American Society of Hematology 121 (9), 1495-1500, 2013 | 643 | 2013 |
| Langerhans cell histiocytosis in adultsReport from the International Registry of the Histiocyte Society M Aricò, M Girschikofsky, T Généreau, C Klersy, K McClain, N Grois, ... European Journal of Cancer 39 (16), 2341-2348, 2003 | 630 | 2003 |
| A human IFNGR1 small deletion hotspot associated with dominant susceptibility to mycobacterial infection E Jouanguy, S Lamhamedi-Cherradi, D Lammas, SE Dorman, ... Nature genetics 21 (4), 370-378, 1999 | 615 | 1999 |
| Attenuated immunochemotherapy regimen (R-miniCHOP) in elderly patients older than 80 years with diffuse large B-cell lymphoma: a multicentre, single-arm, phase 2 trial F Peyrade, F Jardin, C Thieblemont, A Thyss, JF Emile, S Castaigne, ... The Lancet Oncology 12 (5), 460-468, 2011 | 566 | 2011 |
| Hepatosplenic γδ T-cell lymphoma is a rare clinicopathologic entity with poor outcome: report on a series of 21 patients K Belhadj, F Reyes, JP Farcet, H Tilly, C Bastard, R Angonin, E Deconinck, ... Blood 102 (13), 4261-4269, 2003 | 514 | 2003 |
| Partial interferon-gamma receptor 1 deficiency in a child with tuberculoid bacillus Calmette-Guérin infection and a sibling with clinical tuberculosis. E Jouanguy, S Lamhamedi-Cherradi, F Altare, MC Fondanèche, ... The Journal of clinical investigation 100 (11), 2658-2664, 1997 | 479 | 1997 |
| Consensus recommendations for the diagnosis and clinical management of Rosai-Dorfman-Destombes disease O Abla, E Jacobsen, J Picarsic, Z Krenova, R Jaffe, JF Emile, BH Durham, ... Blood, The Journal of the American Society of Hematology 131 (26), 2877-2890, 2018 | 478 | 2018 |
| Percutaneous portal vein embolization increases the feasibility and safety of major liver resection for hepatocellular carcinoma in injured liver D Azoulay, D Castaing, J Krissat, A Smail, GM Hargreaves, A Lemoine, ... Annals of surgery 232 (5), 665-672, 2000 | 474 | 2000 |
| Diverse and targetable kinase alterations drive histiocytic neoplasms EL Diamond, BH Durham, J Haroche, Z Yao, J Ma, SA Parikh, Z Wang, ... Cancer discovery 6 (2), 154-165, 2016 | 470 | 2016 |
| Clinical, biologic, and pathologic features in 157 patients with angioimmunoblastic T-cell lymphoma treated within the Groupe d'Etude des Lymphomes de l'Adulte (GELA) trials N Mourad, N Mounier, J Brière, E Raffoux, A Delmer, A Feller, ... Blood, The Journal of the American Society of Hematology 111 (9), 4463-4470, 2008 | 424 | 2008 |
| Alternatively spliced NKp30 isoforms affect the prognosis of gastrointestinal stromal tumors NF Delahaye, S Rusakiewicz, I Martins, C Ménard, S Roux, L Lyonnet, ... Nature medicine 17 (6), 700-707, 2011 | 402 | 2011 |
